Role of sub-clinical inflammation and defective cholesterol efflux in myocardial infarction patients without standard modifiable risk factors
Sub-clinical inflammation and defective cholesterol efflux were associated with SMuRF-less status of STEMI patients and had prognostic impact. This highlights the need to explore new therapeutic strategies in this high-risk population.
Authors
- Maryse Guérin (ORCID: https://orcid.org/0000-0003-0150-1360)
- Paul Guedeney (ORCID: https://orcid.org/0000-0002-2012-4137)
- Gilles Montalescot (ORCID: https://orcid.org/0000-0003-0824-6809)
- Farzin Beygui (ORCID: https://orcid.org/0000-0003-2170-8983)
- Vincent Roule (ORCID: https://orcid.org/0000-0002-1291-4024)
- Ghilas Rahoual
- Johanne Silvain (ORCID: https://orcid.org/0000-0002-1901-2808)
- Clément Materne (ORCID: https://orcid.org/0000-0003-2605-2231)
- Michel Zeitouni (ORCID: https://orcid.org/0000-0001-9562-3128)
- Mathieu Kernéis (ORCID: https://orcid.org/0000-0002-7141-5209)
- Niki Procopi (ORCID: https://orcid.org/0000-0001-7700-0744)
Institutions
- Inserm (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Normandie Université (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Pitié-Salpêtrière Hospital (FR)
- Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR)
Publication Details
- Journal
- European Heart Journal Acute Cardiovascular Care
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1093/ehjacc/zuaf070
- Citations
- 2
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.71